LONDON – A new and precise method of diagnosing Down syndrome prenatally using a maternal blood sample could be rolled out to clinics within a couple of years, the researchers who developed it anticipate.

LONDON – The Innovative Medicines Initiative (IMI) announced eight new projects with total funding of €172 million, (US$239.1 million) in the next stage of the €2 billion program to redesign the drug discovery and development process and rebuild the competitiveness of Europe's biopharmaceutical sector. (BioWorld International)